GlassScriptPhysician profile
Iran A Gomez
NPI 1811131105
$1,199.19
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,060 · 2020: $139.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $501.19 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.47 | 2019-2020 | |
| Pfizer INC. | $120.43 | 2019 | |
| Lilly USA, LLC | $68.01 | 2019 | |
| Amarin Pharma, INC. | $53.68 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $52.48 | 2019 | |
| Ironwood Pharmaceuticals, INC | $47.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.81 | 2019 | |
| Amgen INC. | $36.76 | 2019 | |
| Allergan, INC. | $34.89 | 2019 | |
| Merck Sharp & Dohme LLC | $24.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.64 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.82 | 2020 | |
| Novartis Pharmaceuticals Corporation | $18.97 | 2019 | |
| Genentech USA, INC. | $18.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iran Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.